Glembatumumab (Anti-GPNMB)
Glembatumumab is a fully human IgG2 monoclonal antibody directed against the extracellular structural domain of GPNMB expressed in human breast cancer and melanoma. MW: 145.5 KD.
Supplier | Selleck Chemicals |
---|---|
Product # | A2475 |
Sku # | A2475-1mg*25 |
Pricing | 1mg*25, $2970.00 |